US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

240.47

+6.432.75%

Post-market: 240.14-0.3266-0.14%19:30 EDT

Volume:10.88K

Turnover:2.60M

Market Cap:482.50M

PE:- -

High:240.47

Open:234.08

Low:234.08

Close:234.03

52wk High:246.55

52wk Low:171.63

Shares:2.01M

Float Shares:2.01M

Volume Ratio:0.89

T/O Rate:0.54%

Dividend:0.96

Dividend Rate:0.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Revolution Medicines (RVMD) Gets a Buy from Goldman Sachs

Sino Biopharmaceutical Stock Slips 1.8% in Hong Kong

Leerink Partners Remains a Hold on Amgen (AMGN)

US Judge Steps Aside in Dispute over Hawaii Energy Settlement

Stoke Therapeutics Names Solid Biosciences CEO Bo Cumbo to Board

Amgen Stock Forecast: AMGN Reclaims $410 as Pipeline Catalysts Build

Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $640 from $633

THOMSON REUTERS

Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Disposes of Common Shares Worth $347,000

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Aytu BioPharma Q4 Revenue Beats Analyst Estimates on EXXUA Sales

Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech

Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Viking Therapeutics (VKTX) and Amgen (AMGN)

Amgen Inc Stock (AMGN) Moved Up by 3.90% on Sep 22: Facts Behind the Movement

Competitive profile of Amgen’s dazodalibep still ‘open question,’ says Citi

Truist sees ‘significant positive readthrough’ for Maze from Vertex data

Maze jumps 25% to $27.99 after Vertex kidney disease data

Amgen Rises After Autoimmune Drug Meets Late-Stage Trial Goal

Amgen Says Dazodalibep Meets Primary Endpoint in Phase 3 Sjögren's Disease Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BBH/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":240.4666,"timestamp":1791576000000,"preClose":234.0318,"halted":0,"volume":10884,"hourTrading":{"tag":"盘后","latestPrice":240.14,"preClose":240.4666,"latestTime":"19:30 EDT","volume":12,"amount":2883.9364,"timestamp":1791588606301,"change":-0.3266,"changeRate":-0.001358,"amplitude":0},"delay":0,"changeRate":0.027495408743598074,"floatShares":2006503,"shares":2006503,"eps":0,"marketStatus":"Market Closed","change":6.4348,"latestTime":"10-09 16:00:00 EDT","open":234.08,"high":240.4666,"low":234.08,"amount":2595064.39236,"amplitude":0.027289,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":234.0318,"sharesOutstanding":1976503,"nav":240.40394,"aum":484775263.27,"dividendRate":0.00399,"bidAskSpread":0.001167,"postHourTrading":{"tag":"盘后","latestPrice":240.14,"preClose":240.4666,"latestTime":"19:30 EDT","volume":12,"amount":2883.9364,"timestamp":1791588606301,"change":-0.3266,"changeRate":-0.001358,"amplitude":0},"volumeRatio":0.8922189170173007,"impliedVol":0.1795,"impliedVolPercentile":0.2191},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":2006503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8922189170173007,"shares":2006503,"dividePrice":0.9595,"high":240.4666,"amplitude":0.027289,"preClose":234.0318,"low":234.08,"week52Low":171.63,"pbRate":"--","week52High":246.55,"institutionHeld":0,"latestPrice":240.4666,"eps":0,"divideRate":0.00399,"volume":10884,"delay":0,"ttmEps":0,"open":234.08,"prevYearClose":189.2649,"prevWeekClose":237.4531,"prevMonthClose":244.575,"prevQuarterClose":244.575,"fiveDayClose":237.4531,"twentyDayClose":229.3922,"sixtyDayClose":206.2544},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669918463","title":"Revolution Medicines (RVMD) Gets a Buy from Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669918463","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669918463?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:35","pubTimestamp":1790238933,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Andrea Newkirk resumed coverage with a Buy rating on Revolution Medicines today and set a price target of $267.00. Newkirk co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/revolution-medicines-rvmd-gets-a-buy-from-goldman-sachs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/revolution-medicines-rvmd-gets-a-buy-from-goldman-sachs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4552","LU2237443622.USD","IE00BJJMRZ35.SGD","LU0096364046.USD","LU0942090050.USD","IE00BJT1NW94.SGD","LU0345770308.USD","LU0210536198.USD","LU1144417596.USD","LU0109394709.USD","LU0345770993.USD","LU1791807156.HKD","LU2237443382.USD","GSX","LU0868494708.USD","BBH","BK4127","IE00BFTCPJ56.SGD","BK4550","LU0742534661.SGD","IE0002270589.USD","LU0251131958.USD","IE00B2B36J28.USD","LU0251142724.SGD","BK4588","LU2237443895.HKD","IE00B19Z3B42.SGD","LU1868836591.USD","PTH","LU2750360997.AUD","IE0034235188.USD","IE0004086264.USD","RVMD","IE00BFXG1179.USD","LU2471134523.USD","LU1668664300.SGD","IE00BSNM7G36.USD","LU1894683264.USD","LU0106831901.USD","LU1804176565.USD","BK4533","LU1894683348.USD","IE0009354923.USD","LU2896262040.SGD","LU2237438978.USD","LU0061475181.USD","LU2237443978.SGD","LU1868836757.USD","CANC","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669463318","title":"Sino Biopharmaceutical Stock Slips 1.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2669463318","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669463318?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:31","pubTimestamp":1790238660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.8% to 5.59 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.3% to 24761.13.This was the stock's third consecutive day of losses.Sino Biopharmaceutical Ltd. closed 35% below its 52-week high of HK$8.54, which the company reached Oct. 8.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 3.2% and Amgen Inc. remained unchanged.Trading volume totaled 52.8 million shares, compared to the 50-day average of 85.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","PBE","LU2089984988.USD","LU2242646821.SGD","IE00B2B36J28.USD","LU0122379950.USD","BK4139","IE00B4R5TH58.HKD","LU0320765992.SGD","BK1589","BIB","IE00BZ08YR35.GBP","LU2468319806.SGD","BK4534","IBB","BK4588","LU0058720904.USD","IE0002141913.USD","LU0289739699.SGD","LU1023059063.AUD","LU1061106388.HKD","LU1571399168.USD","BK4566","IE00BFTCPJ56.SGD","LU1057294990.SGD","BBH","BK1515","IE00BZ08YS42.EUR","IE00BJJMRZ35.SGD","BK4581","PJP","LU2112291526.USD","IE0009355771.USD","BK4585","LU0109394709.USD","IE00BZ08YT58.USD","AMGN","LU0889565916.HKD","BK4533","TBXU","BK4599","SG9999001440.SGD","LU1983299246.USD","HK0000165453.HKD","LU2242652126.USD","BK1521","IBBQ","LU0868494617.USD","IE00BJT1NW94.SGD","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669381451","title":"Leerink Partners Remains a Hold on Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669381451","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669381451?lang=en_us&edition=fundamental","pubTime":"2026-09-24 13:15","pubTimestamp":1790226924,"startTime":"0","endTime":"0","summary":"In a report released yesterday, from Leerink Partners maintained a Hold rating on Amgen. The company’s shares closed yesterday at $406.09. In addit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/leerink-partners-remains-a-hold-on-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/leerink-partners-remains-a-hold-on-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2242646821.SGD","LU1983299246.USD","IE00B2B36J28.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","AMGN","LU0058720904.USD","IE00BJT1NW94.SGD","BK4139","BK4599","IE0009355771.USD","LU2468319806.SGD","PJP","BBH","IBBQ","BK4534","LU0320765992.SGD","BK4581","LU0868494617.USD","LU1057294990.SGD","LU0122379950.USD","BIB","LU2242652126.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","BK4533","IE00BJJMRZ35.SGD","BK4585","LU0289739699.SGD","BK4588","LU2112291526.USD","IE0002141913.USD","BK4566","LU2089984988.USD","IBB","LU1023059063.AUD","TBXU","SG9999001440.SGD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669843952","title":"US Judge Steps Aside in Dispute over Hawaii Energy Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669843952","media":"Reuters","labels":["policyRegulatory","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669843952?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:00","pubTimestamp":1790197259,"startTime":"0","endTime":"0","summary":"US judge steps aside in dispute over Hawaii energy settlementSept 23 (Reuters)-A federal judge in Hawaii has disqualified himself from hearing a dispute over whether a decades-old price-fixing settlem","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL6N45F14Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","GXPE","IGE","BK4559","TBXU","TMED","BBH","LU0265550946.USD","IBBQ","LU0942090050.USD","LU1929549753.HKD","SG9999002521.SGD","LU2468319806.SGD","TRUN","DIG","LU0861579265.USD","LU0256863811.USD","LU2129689605.HKD","BK4588","TEXU","GILD","IE0002270589.USD","BIB","BMED","LU0265550359.USD","LU0868494708.USD","WEEI","IBB","FENY","IE00B19Z3B42.SGD","BK4201","ERX","LU1037948541.HKD","MEDI","FTXN","LU0640476718.USD","LU0122376428.USD","LU0098860793.USD","CVX","IYE","IXC","LU0300736062.USD","LU0456854461.SGD","LU0234570918.USD","XLE","LU0965509010.AUD","VDE","IE00B3T34201.USD","LU0149725797.USD","DRLL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669090435","title":"Stoke Therapeutics Names Solid Biosciences CEO Bo Cumbo to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2669090435","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669090435?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:01","pubTimestamp":1790193684,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics names Solid Biosciences CEO Bo Cumbo to boardStoke Therapeutics appointed Bo Cumbo to its board.Edward Kaye retired as a director; he served on the board since 2017 and was CEO from","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL9kWWfM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU1066053197.SGD","LU0859254822.USD","SRPU","LU0109394709.USD","BK4139","IE00B2B36J28.USD","SRPT","BK4585","IE00BZ1G4Q59.USD","LU0320765992.SGD","BK4588","IE00B19Z3B42.SGD","IE0002141913.USD","LU1061106388.HKD","LU0965509101.SGD","LU2468319806.SGD","TBXU","LU1023059063.AUD","LU1934455277.USD","LU1778281490.HKD","IE0002270589.USD","GILD","LU2112291526.USD","STOK","LU2087621335.USD","BIB","IE00BKVL7J92.USD","IBB","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","BK4578","LU0122379950.USD","LU1037948541.HKD","IBBQ","LU1674673691.USD","BK4550","TMED","IE0009355771.USD","LU0882574055.USD","MEDI","IE00BSNM7G36.USD","LU1674673428.USD","LU1934455194.USD","BMED","LU0889565916.HKD","SLDB","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669646482","title":"Amgen Stock Forecast: AMGN Reclaims $410 as Pipeline Catalysts Build","url":"https://stock-news.laohu8.com/highlight/detail?id=2669646482","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669646482?lang=en_us&edition=fundamental","pubTime":"2026-09-23 23:00","pubTimestamp":1790175600,"startTime":"0","endTime":"0","summary":"Amgen rebounds to $410.24 as dazodalibep and IMDELLTRA strengthen the pipeline while $418.73 becomes the next technical test.\n","market":"fut","thumbnail":"https://resource.tradingkey.com/uploads/20260923/AMGEN-82b57eea98fd4d6fa458e68c35b3ab95.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260923/AMGEN-82b57eea98fd4d6fa458e68c35b3ab95.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262182585-stocks-amgen-stock-forecast-pipeline-410-breakout-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLS","IE0009355771.USD","PFS","BBH","LU0868494617.USD","TSLT","TSLY","09766","TEST","LU2237443549.SGD","ORR.AU","CRSH","07766","TSLI","TSLG","TSLW","07366","TSL","TSDD","TSLQ","IE0002141913.USD","PJP","AZNH","PBE","ORR","IBB","AZN","LU1983299246.USD","TBXU","TSYY","IBBQ","TSII","TESC","09366","TSLO","TSLL","TSLR","AMGN","TSLP","LU1571399168.USD","BK7095","TLA","TESL","LU2468319806.SGD","ELOL","TSLZ","BIB","LU2242652126.USD","BGSX","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669648508","title":"Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669648508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669648508?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:30","pubTimestamp":1790166641,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nek...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-vertex-pharmaceuticals-vrtx-and-nektar-therapeutics-nktr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-vertex-pharmaceuticals-vrtx-and-nektar-therapeutics-nktr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","LU0823416689.USD","IBB","IE00B894F039.SGD","IE00BZ9MQY76.HKD","LU0109394709.USD","NKTR","LU0432979614.USD","LU1674673428.USD","LU0256863811.USD","LU1559883803.SGD","LU2362541513.USD","LU2237438978.USD","TBXU","LU2417539215.USD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","BK4023","LU0417517546.SGD","IE0002141913.USD","PBE","BK4007","LU1069344957.HKD","IE0002270589.USD","BK4585","LU0061475181.USD","BK4139","IE00B19Z3581.USD","LU0757428866.USD","HCSG","BIB","VRTX","LU2324357040.USD","SG9999001176.USD","XLV","IE00BFTCPJ56.SGD","LU0234570918.USD","IDNA","VERX","BBH","KYMR","LU1035775433.USD","XBI","GNMX","LU0289739699.SGD","SG9999001176.SGD","LU2089984988.USD","IBBQ","LABU","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669711101","title":"Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669711101","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669711101?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:10","pubTimestamp":1790154626,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Quest Diagnostics (DGX), AnaptysBio (ANAB) and Verte...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-anaptysbio-anab-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-anaptysbio-anab-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999001176.USD","XLV","SG9999001176.SGD","LU0234570918.USD","LU2506951875.HKD","XBI","LU1585245621.USD","IDNA","LU0757428866.USD","FFTY","IBB","LU2462157665.USD","LU2506952097.USD","LU1035775433.USD","BIB","BK4583","IBBQ","LU1815336091.USD","VERX","IE00B19Z3B42.SGD","IE00BZ9MQY76.HKD","BBH","LU0417517546.SGD","LU1854103824.USD","LU2506952170.USD","LABU","IE00B2B36J28.USD","TBXU","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU2089984988.USD","LU0079474960.USD","HCSG","ANAB","LU0109394709.USD","IE0002270589.USD","IE0009355771.USD","BK4139","IE00BJT1NW94.SGD","SGXZ57979304.SGD","DGX","GNMX","VRTX","PBE","LU0823417737.USD","LU0823416689.USD","BK4567","LU0823417653.USD","LU2456880835.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669999174","title":"Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $640 from $633","url":"https://stock-news.laohu8.com/highlight/detail?id=2669999174","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669999174?lang=en_us&edition=fundamental","pubTime":"2026-09-23 11:36","pubTimestamp":1790134588,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45E0RF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBBQ","TBXU","IE00B19Z9P08.USD","LU0889565916.HKD","IE0002141913.USD","PBE","LU1585245621.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","IDNA","VRTX","BBH","LU1674673428.USD","BK4567","LU2462157665.USD","LU0061475181.USD","LU0109394709.USD","LU1035775433.USD","LU0234570918.USD","LU1069344957.HKD","LU1778281490.HKD","IE00B2B36J28.USD","SG9999001176.USD","LU1093756325.SGD","LU0058720904.USD","IBB","BK4585","LU2456880835.USD","LU2468319806.SGD","IE00B19Z3581.USD","LU2417539215.USD","BIB","LU0432979614.USD","LU1093756168.USD","BK4588","LU2362540622.SGD","SG9999013999.USD","IE00BFTCPJ56.SGD","BK4139","IE0002270589.USD","IE00B4R5TH58.HKD","IE00B894F039.SGD","IE00B19Z9Z06.USD","GNMX","LU2237438978.USD","SGXZ57979304.SGD","IE0009355771.USD","LU2362541273.HKD","IE00BZ9MQY76.HKD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669120310","title":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Disposes of Common Shares Worth $347,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2669120310","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669120310?lang=en_us&edition=fundamental","pubTime":"2026-09-23 06:00","pubTimestamp":1790114446,"startTime":"0","endTime":"0","summary":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini disposes of common shares worth $347,000Revolution Medicines Chief Global Commercialization Officer Anthony Mancini sold 1,7","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL64Mcy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Disposes of Common Shares Worth $347,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU0109394709.USD","CANC","BBH","BK4139","IDNA","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0889565916.HKD","PTH","IE00B4R5TH58.HKD","LU0320765992.SGD","IE0009354923.USD","RVMD","IE00BJT1NW94.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669171122","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2669171122","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669171122?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:34","pubTimestamp":1790109240,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 1.40% to $152.67 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  remaining mostly unchanged at 7,764.64 and the Dow Jones Industrial Average  falling 0.36% to 51,863.69.This was the stock's second consecutive day of gains.Gilead Sciences Inc. closed 2.94% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  fell 0.10% to $269.19, Pfizer Inc.  rose 0.68% to $27.93, and Abbott Laboratories  rose 0.69% to $103.69.Trading volume  remained 1.3 million below its 50-day average volume of 6.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 22, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BK4139","LU0114720955.EUR","LU1571399168.USD","LU1934455277.USD","TMED","LU2468319806.SGD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","LU0234570918.USD","LU2087621335.USD","LU2089984988.USD","BK4585","SG9999015978.USD","LU0882574055.USD","LU1934455863.HKD","IBBQ","BK4532","LU0965508806.USD","IE00B3T34201.USD","LU1839511570.USD","BK4568","LU0289739699.SGD","MEDI","LU0058720904.USD","LU0965509010.AUD","IE00B7SZLL34.SGD","LU0122379950.USD","BK4566","LU0889565916.HKD","LU2112291526.USD","LU1037948541.HKD","BK4588","LU1037948897.HKD","BMED","IE00B19Z3B42.SGD","LU0965509101.SGD","LU1057294990.SGD","LU0320765992.SGD","LU1430594728.SGD","LU0859254822.USD","IBB","LU0823416689.USD","LU0965509283.SGD","LU1066051498.USD","LU1674673428.USD","LU2324357040.USD","SG9999015945.SGD","BK4583","LU2357627491.SGD","LU0109394709.USD","SG9999015986.USD","BK4578","BK4550","LU1585245621.USD","LU1061106388.HKD","LU1778281490.HKD","LU0861579265.USD","LU1066053197.SGD","LU1934455194.USD","IE0002270589.USD","SG9999015952.SGD","LU1023059063.AUD","GILD","IE00B19Z3581.USD","TBXU","BBH","BIB","LU1674673691.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669577122","title":"Aytu BioPharma Q4 Revenue Beats Analyst Estimates on EXXUA Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2669577122","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669577122?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:17","pubTimestamp":1790108275,"startTime":"0","endTime":"0","summary":"Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA salesOverviewUS pharmaceutical firm's fiscal Q4 revenue rose 6.4%, beating analyst expectationsCompany reported near break-even net loss for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL1N45E0WU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","LU2089984988.USD","LU2242646821.SGD","IE00B2B36J28.USD","LU0122379950.USD","BK4139","IE00B4R5TH58.HKD","LU0320765992.SGD","BIB","LU2468319806.SGD","BK4534","IBB","BK4588","LU0058720904.USD","IE0002141913.USD","LU0289739699.SGD","LU1023059063.AUD","LU1061106388.HKD","LU1571399168.USD","BK4566","IE00BFTCPJ56.SGD","LU1057294990.SGD","BBH","PJP","IE00BJJMRZ35.SGD","BK4581","LU2112291526.USD","IE0009355771.USD","BK4585","AYTU","LU0109394709.USD","AMGN","LU0889565916.HKD","BK4533","TBXU","BK4599","SG9999001440.SGD","LU1983299246.USD","LU2242652126.USD","IBBQ","LU0868494617.USD","BK4007","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669412656","title":"Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2669412656","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669412656?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:47","pubTimestamp":1790095620,"startTime":"0","endTime":"0","summary":"Shares of biopharmaceutical company Maze Therapeutics jumped after competitor Vertex Pharmaceuticals reported positive study results for its kidney disease drug, signaling strong commercial potential ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE0002141913.USD","XBI","LU0079474960.USD","LU1778281490.HKD","IE00B894F039.SGD","IE00BJT1NW94.SGD","GNMX","IBB","LU0234570918.USD","BK4532","BK4567","LU0889565916.HKD","LU2089984988.USD","BK4023","LU1430594728.SGD","SGXZ57979304.SGD","IE00B19Z3581.USD","BK4585","TBXU","IBBQ","LU1069344957.HKD","LU2462157665.USD","LU1815336091.USD","LU2324357040.USD","LU1559883803.SGD","LU2236285917.USD","LU1585245621.USD","IE00B19Z9Z06.USD","IDNA","IE00B2B36J28.USD","VERX","PBE","LU1674673428.USD","LU0256863811.USD","LU0289739699.SGD","IE00BZ9MQY76.HKD","BBH","LU2456880835.USD","LU1035775433.USD","MAZE","LU1093756168.USD","LU2362541513.USD","LU0432979614.USD","BIB","IE00BFTCPJ56.SGD","LU0058720904.USD","VRTX","LU2237438978.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669757123","title":"Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Viking Therapeutics (VKTX) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669757123","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669757123?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:20","pubTimestamp":1790090418,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eledon Pharmaceuticals (ELDN), Viking Therapeutics (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eledon-pharmaceuticals-eldn-viking-therapeutics-vktx-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eledon-pharmaceuticals-eldn-viking-therapeutics-vktx-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2468319806.SGD","LABU","OZEM","IBBQ","IE0009355771.USD","LU0128526141.USD","BK4566","LU2242646821.SGD","PBE","THNR","IE00BJT1NW94.SGD","XBI","IBB","LU1061106388.HKD","SG9999001440.SGD","IE00BJJMRZ35.SGD","BK4533","LU0109394709.USD","BK4585","BK4139","AMGN","BK4534","LU0029874061.USD","LU1057294990.SGD","LU1571399168.USD","LU0868494617.USD","HCSG","LU0320765992.SGD","LU0058720904.USD","LU2089984988.USD","BK4599","LU0889565916.HKD","IE00B2B36J28.USD","LU1983299246.USD","LU2112291526.USD","LU2242652126.USD","LU0122379950.USD","XLV","IE00BFTCPJ56.SGD","PJP","IE00B4R5TH58.HKD","VKTX","BK4137","BK4588","LU0289739699.SGD","TBXU","BIB","BBH","ELDN","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669123184","title":"Amgen Inc Stock (AMGN) Moved Up by 3.90% on Sep 22: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669123184","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669123184?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:15","pubTimestamp":1790090123,"startTime":"0","endTime":"0","summary":"• Amgen shares rose following positive Phase 3 OASIZ 301 trial results for dazodalibep.  \n• The company reported an annual revenue of $36.75B and a net profit of $7.71B.  \n• Analysts hold an average price target of $389.14 with a Hold rating.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262180812-market-movers-amgn-20260922","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE00B4R5TH58.HKD","LU1057294990.SGD","BK4139","LU0289739699.SGD","LU0109394709.USD","LU1061106388.HKD","LU2242652126.USD","BBH","LU0122379950.USD","04332","BK4599","PBE","IBBQ","LU2089984988.USD","AMGN","LU0889565916.HKD","LU1571399168.USD","BK4566","IE00BJT1NW94.SGD","BIB","BK4588","LU2242646821.SGD","PJP","LU0868494617.USD","IE0002141913.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","TBXU","BK4533","LU0320765992.SGD","LU1023059063.AUD","IBB","IE0009355771.USD","LU1983299246.USD","BK4585","BK4581","LU2112291526.USD","SG9999001440.SGD","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669821123","title":"Competitive profile of Amgen’s dazodalibep still ‘open question,’ says Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2669821123","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669821123?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:55","pubTimestamp":1790088920,"startTime":"0","endTime":"0","summary":"Citi says Amgen’s (AMGN) dazodalibep delivered “positive” Phase 3 results in systemic Sjogren’s, which reduces clinical risk for “a potentially und...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/competitive-profile-of-amgens-dazodalibep-still-open-question-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/competitive-profile-of-amgens-dazodalibep-still-open-question-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BIB","LU2468319806.SGD","BK4534","AMGN","LU0122379950.USD","TBXU","LU0320765992.SGD","LU2089984988.USD","BK4581","BK4139","IE00BFTCPJ56.SGD","BK4566","BK4599","LU2242646821.SGD","LU2112291526.USD","LU0058720904.USD","BK4585","LU1057294990.SGD","BBH","LU1061106388.HKD","LU0889565916.HKD","LU0868494617.USD","IBBQ","IE00B4R5TH58.HKD","LU2242652126.USD","IE00BJT1NW94.SGD","PJP","IE00BJJMRZ35.SGD","LU1983299246.USD","LU0109394709.USD","PBE","IE00B2B36J28.USD","BK4533","IBB","IE0002141913.USD","LU0289739699.SGD","SG9999001440.SGD","LU1023059063.AUD","LU1571399168.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669128999","title":"Truist sees ‘significant positive readthrough’ for Maze from Vertex data","url":"https://stock-news.laohu8.com/highlight/detail?id=2669128999","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669128999?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:30","pubTimestamp":1790087413,"startTime":"0","endTime":"0","summary":"Truist analyst Danielle Brill views Vertex’s (VRTX) positive Phase 2 topline data as a meaningful validation of APOL1 inhibition in classic APOL1-m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/truist-sees-significant-positive-readthrough-for-maze-from-vertex-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/truist-sees-significant-positive-readthrough-for-maze-from-vertex-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756168.USD","LU1674673691.USD","IDNA","VERX","IE00BJJMRZ35.SGD","BBH","PBE","IE00B894F039.SGD","LU0079474960.USD","LU0320765992.SGD","LU2362540622.SGD","LU1035775433.USD","LU2456880835.USD","IE00BZ9MQY76.HKD","LU0889565916.HKD","SG9999013999.USD","BK4585","LU1778281490.HKD","LU0757428866.USD","BK4023","BIB","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","SGXZ57979304.SGD","LU0256863811.USD","VRTX","IE00B19Z3B42.SGD","LU2362541513.USD","IE0009355771.USD","IE0002141913.USD","LU0058720904.USD","GNMX","LU0823416689.USD","IBB","IBBQ","LU1674673428.USD","LU2462157665.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","LU1559883803.SGD","LU1093756325.SGD","LU0061475181.USD","BK4533","LU2089984988.USD","BK4532","IE00B19Z3581.USD","TBXU","IE0002270589.USD","LU1069344957.HKD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669919128","title":"Maze jumps 25% to $27.99 after Vertex kidney disease data","url":"https://stock-news.laohu8.com/highlight/detail?id=2669919128","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669919128?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:25","pubTimestamp":1790087125,"startTime":"0","endTime":"0","summary":"10:23 EDT Maze jumps 25% to $27.99 after Vertex kidney disease data Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-jumps-25-to-27-99-after-vertex-kidney-disease-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-jumps-25-to-27-99-after-vertex-kidney-disease-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VRTX","GNMX","IE00B19Z9Z06.USD","LU0432979614.USD","IE00B894F039.SGD","LU1778281490.HKD","SG9999013999.USD","IE00B19Z9P08.USD","IE0002270589.USD","LU2456880835.USD","IBBQ","LU1815336091.USD","LU1559883803.SGD","IE0009355771.USD","LU1585245621.USD","PBE","IE00BJT1NW94.SGD","LU2462157665.USD","IBB","LU0079474960.USD","LU2236285917.USD","BK4533","LU0109394709.USD","BK4585","BK4139","LU0234570918.USD","LU2089984988.USD","BK4567","LU0320765992.SGD","LU0058720904.USD","LU2417539215.USD","IDNA","LU1674673428.USD","LU0889565916.HKD","IE00B19Z3581.USD","LU2362541513.USD","LU1093756325.SGD","LU2362541273.HKD","IE00BFTCPJ56.SGD","IE00BZ9MQY76.HKD","SGXZ57979304.SGD","VERX","LU0256863811.USD","LU0289739699.SGD","BIB","TBXU","BK4023","BBH","LU1093756168.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669470171","title":"Amgen Rises After Autoimmune Drug Meets Late-Stage Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669470171","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669470171?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:48","pubTimestamp":1790084894,"startTime":"0","endTime":"0","summary":"BUZZ-Amgen rises after autoimmune drug meets late-stage trial goal** Shares of drugmaker AmgenAMGN.Orise 2.4% to $402.69** Co says its experimental drug, dazodalibep, for Sjogren's diseasemet the main goalof reducing disease activity in a late-stage trial** Sjogren's disease is an autoimmune disorder that causes dryness of the eyes, mouth and other parts of the body, along with fatigue and chronic pain** Drug showed a statistically significant and clinically meaningful improvement at week 48; most side effects were mild to moderate** Co plans to present detailed results at an upcoming medical meeting** Including session's move, AMGN up 23.1% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0WO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","BK4581","LU1571399168.USD","LU2468319806.SGD","LU2242652126.USD","IE0009355771.USD","BIB","AMGN","IE00B4R5TH58.HKD","BK4585","BK4588","IBB","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU2112291526.USD","LU1057294990.SGD","IE0002141913.USD","IE00B2B36J28.USD","PBE","LU2242646821.SGD","BK4533","LU0289739699.SGD","IE00BJT1NW94.SGD","SG9999001440.SGD","LU1061106388.HKD","PJP","BK4534","BK4566","BK4599","IE00BFTCPJ56.SGD","IBBQ","LU0058720904.USD","LU0320765992.SGD","LU0122379950.USD","LU1983299246.USD","LU2089984988.USD","BK4139","TBXU","LU0868494617.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147050","title":"Amgen Says Dazodalibep Meets Primary Endpoint in Phase 3 Sjögren's Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147050","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147050?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:45","pubTimestamp":1790084715,"startTime":"0","endTime":"0","summary":"Sept 22 (Reuters) - Amgen Inc::*AMGEN: PHASE 3 OASIZ 303 STUDY OF DAZODALIBEP IN MODERATE-TO-SEVERE SYMPTOMATIC SJGREN’S DISEASE EXPECTED TO COMPLETE IN Q4 2026*AMGEN: DAZODALIBEP MEETS PRIMARY ENDPOI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nRSDcc0x9T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","LU1983299246.USD","IE00B2B36J28.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","AMGN","LU0058720904.USD","IE00BJT1NW94.SGD","BK4139","BK4599","IE0009355771.USD","LU2468319806.SGD","PJP","BBH","IBBQ","BK4534","LU0320765992.SGD","BK4581","LU0868494617.USD","LU1057294990.SGD","LU0122379950.USD","BIB","LU2242652126.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","BK4533","IE00BJJMRZ35.SGD","BK4585","LU0289739699.SGD","BK4588","LU2112291526.USD","IE0002141913.USD","BK4566","LU2089984988.USD","IBB","LU1023059063.AUD","TBXU","SG9999001440.SGD","PBE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}